300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Iran
Kyrgyzstan
Guinea
Nepal
Pakistan
Isle of Man
Romania
Oman
Cameroon
Australia
Colombia
New Zealand
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Malawi
Moldova
Botswana
Japan
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science VC Funds & Investors in South Korea (July 2026)

The most active venture capital funds investing in South Korea Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in South Korea Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Korea Technology Finance Corporation
VC Fund
3 South Korea, Russian Federation Seed, Series A, Series B Software, Manufacturing, Medical $1k–$15M
Mirae Asset Venture Investment
VC Fund
3 South Korea, United States, India Series A, Series B, Seed Software, Biotechnology, Artificial Intelligence $594k–$54M
Series Ventures
VC Fund
3 South Korea, Singapore Seed, Series A Health Care, Manufacturing, Biotechnology $74k–$4.4M
Ulmus Investment
VC Fund
2 South Korea, United Kingdom Series A, Series B, Series C Biotechnology, Artificial Intelligence, Manufacturing $3k–$63M
Aju IB Investment
VC Fund
2 South Korea, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Therapeutics
Devsisters Ventures
VC Fund
2 South Korea, United States, Russian Federation Series A, Seed Software, Gaming, Biotechnology $1k–$7.8M
Korea Investment Partners
VC Fund
2 South Korea, United States, China Series A, Series B, Seed Biotechnology, Information Technology, Health Care $973k–$50M
SJ Investment Partners
VC Fund
2 South Korea, United States, Hong Kong Series A, Series B, Seed Biotechnology, Manufacturing, Medical $547k–$28M
UTC Investment Co.
VC Fund
2 South Korea, United States, Japan Series A, Series B Biotechnology, Health Care, Medical $2M–$20M
Kakao Ventures
VC Fund
2 South Korea, United States, Indonesia Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $297k–$27M
Medytox Venture Investment
VC Fund
2 South Korea Series A, Series B, Series C Biotechnology, Pharmaceutical, Medical $3k–$44M
Industrial Bank of Korea
VC Fund
2 South Korea, United States, China Series A, Series B, Seed Software, Artificial Intelligence, Information Technology $149k–$29M
BSK Investment
VC Fund
2 South Korea Series A, Series B, Series C Biotechnology, Health Care, Artificial Intelligence $2.4M–$57M
Yuhan Corporation
VC Fund
2 South Korea Series B, Series C, Corporate Round Health Care, Biotechnology, Medical $2k–$40B
Boditech Med
VC Fund
2 South Korea Seed, Series A Life Science, Biotechnology, Bioinformatics
Coolidge Corner Investment
VC Fund
2 South Korea, United States, Belgium Seed, Series A, Series B Software, Manufacturing, Health Care $223k–$11M
HG Initiative
VC Fund
2 South Korea, United States Series A, Seed, Series B Health Care, Biotechnology, Medical $360k–$13M
Quantum Ventures Korea
VC Fund
2 South Korea, United States Series A, Series B, Seed Software, Medical, Information Technology $1M–$54M
Yuanta Investment
VC Fund
1 South Korea, Taiwan, Vietnam Series B, Series C, Series A Financial Services, Information Technology, E-Commerce
Stick Ventures
VC Fund
1 South Korea Series B, Series A Biotechnology, Information Technology, Pharmaceutical
Mirae Asset Capital
VC Fund
1 South Korea, United States, India Series B, Series A, Series C Health Care, Biotechnology, Medical $6k–$255M
Shinhan Venture Investment
VC Fund
1 South Korea, United States, Japan Series B, Series A Biotechnology, Manufacturing, Software $2.2M–$45M
Clarevoyant Ventures
VC Fund
1 South Korea Series A, Series B Medical, Health Care, Life Science
Kiwoom Investment
VC Fund
1 South Korea, United States, Japan Series B, Series A, Series C Information Technology, Software, Biotechnology $1.2M–$33M
Kingo Investment Partners
VC Fund
1 South Korea Series C, Series A, Series B Biotechnology, Health Care, Therapeutics $2k–$37M
Neoflux
VC Fund
1 South Korea, United States Series A, Series B Software, Apps, Information Technology $3k–$10M
Timepolio Asset Management
VC Fund
1 South Korea, United States, Russian Federation Series A, Series B, Series C Biotechnology, Manufacturing, Health Care $9k–$81M
Cytogen
VC Fund
1 South Korea Series A Life Science, Biotechnology, Pharmaceutical
Widwin Investment
VC Fund
1 South Korea, United States Series B, Series C, Series A Biotechnology, Medical, Health Care $497k–$47M
JCurve Investment
VC Fund
1 South Korea Series A, Series B, Seed Medical, Pet, Apps $4.6M–$14M
Ost Investment
VC Fund
1 South Korea Series A, Seed Biotechnology, Health Care, Therapeutics
Future Science and Technology Holdings
VC Fund
1 South Korea, United States Seed, Series A Health Care, Biotechnology, Food and Beverage $231k–$3.7M
KB Securities
VC Fund
1 South Korea, United States, China Series B, Series A, Post-IPO Equity Software, Information Technology, Health Care $82–$22M
Time Folio Asset Management
VC Fund
1 South Korea, United States Series B, Series C, Series A Biotechnology, Pharmaceutical, Health Care $4.8M–$33M
JX Partners
VC Fund
1 South Korea Series A, Series C, Series B Biotechnology, Health Care, Biopharma $5.9M–$33M
Meritz Securities
VC Fund
1 South Korea, China Series C, Series A, Series B Medical, Biotechnology, Pharmaceutical $4.7M–$37M
Nice Investment Partners
VC Fund
1 South Korea, Japan Series A, Series B, Seed Health Care, Information Technology, Software $1k–$22M
Quad Asset Management
VC Fund
1 South Korea, United States Series B, Series A, Series C Biotechnology, Pharmaceutical, Medical $1.5M–$42M
IBK Capital
VC Fund
1 South Korea, United States, India Series A, Seed, Series B Health Care, Biotechnology, Information Technology $2k–$21M
The Wells Investment
VC Fund
1 South Korea Series A, Series B, Series C Health Care, Biotechnology, Artificial Intelligence $2.2M–$15M
Premier Partners
VC Fund
1 South Korea, United States, Russian Federation Series B, Series A Biotechnology, Health Care, Artificial Intelligence $2.2M–$45M
HB Investment
VC Fund
1 South Korea, United States, Vietnam Series B, Series A Software, Biotechnology, Artificial Intelligence $1.1M–$23M
Stonebridge Ventures
VC Fund
1 South Korea, United States, Japan Series B, Series A, Seed Artificial Intelligence, Biotechnology, Software $736k–$17M
SV Investment Corp
VC Fund
1 South Korea, United States, China Series A, Series B, Seed Software, Information Technology, Artificial Intelligence $1.2M–$60M
P&I Investment
VC Fund
1 South Korea Series A, Seed Music, Content, Software $7.4M–$36M
Partners Investment
VC Fund
1 South Korea, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Software $2.1M–$117M
BNH Investment
VC Fund
1 South Korea, United States Series B, Series A, Series C Biotechnology, Pharmaceutical, Medical $7k–$23M
STIC Ventures
VC Fund
1 South Korea, United States, Vietnam Series A, Series B Biotechnology, Artificial Intelligence, Information Technology $2M–$46M
Korea Omega Investment
VC Fund
1 South Korea, Vietnam, United States Series A, Series B, Seed Biotechnology, Medical, Health Care $5k–$59M
ActnerLab
VC Fund
1 South Korea, United States, Japan Seed, Angel Health Care, Medical, Medical Device $37k–$111k
Access all 141 VC funds in South Korea Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Korea Technology Finance Corporation
VC Fund · Busan, Pusan-jikhalsi, South Korea · 3 investments in South Korea Life Science startups, 8 in the past 12 months

Korea Technology Finance Corporation is a South Korea-based fund for small and medium enterprises.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Medical
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, Russian Federation

Investor stats

  • Total investments: 87
  • Round size: Seed $1k–$4.1M; Series A $2k–$7.4M; Series B $7k–$15M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Sodamsodam — Sodamsodam is a meat processing and home meal replacement (HMR) manufacturing company. They secure cost competitiveness by directly deboning and shaping beef and pork, utilizing all parts. They produce their products using a combination of cast-iron pot heating and modern equipment.
  • Elevenliter — Eleven Liter operates Lipet, an online health check solution for companion animals.
  • Intergravity — Intergravity is a company that is developing orbital transportation technologies to support the future of in-space activity. Intergravity is to enable a space environment in which mobility, service, and logistics are seamlessly integrated, creating the framework for long-term operations beyond Earth.
Show all investments...

Mirae Asset Venture Investment
VC Fund · Seongnam, Kyonggi-do, South Korea · 3 investments in South Korea Life Science startups

Mirae Asset Venture Investment invests in specialized enterprises and provides technology, funding and management consulting.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 283
  • Round size: Seed $594k–$12M; Series A $1.7M–$38M; Series B $3.7M–$54M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • Asteromorph — We are an AI for Science lab in Seoul. Our mission is to accelerate scientific advancements through the pursuit of superintelligence.
  • Ohouse — No.1 Interior Onestop Platform
Show all investments...

Series Ventures
VC Fund · Changwon, Kyongsang-namdo, South Korea · 3 investments in South Korea Life Science startups

Series Ventures is an investment company for the beauty care, engineering, healthcare, social platform, and enterprise sectors.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Biotechnology
  • Stage:Seed, Series A
  • Geography: South Korea, Singapore

Investor stats

  • Total investments: 94
  • Round size: Seed $74k–$1.6M; Series A $2.4M–$4.4M
  • Lead/follow: 69% lead, 31% follow

Portfolio highlights

  • TouchMeal — TouchMind (operating as TouchMeal) runs an AI-driven senior foodtech platform that manages professional institutional catering, customized dietary meal planning, and automated ingredient supply chains for nursing homes. The company handles full kitchen management operations, including hygiene standards compliance, staff management, and thedistribution of specialized elderly-friendly food products.
  • XYZ — LoungeLAB is a Retail-tech startup that augments space with technology, using the state-of-the-art technologies such as AI and Robotics technology. LoungeLAB focuses on enhancing the product value and services, and we develop in the field rather than on the desk. We Invent Everyday Technology for All.
  • ROBOS — Robos is a hybrid robot system built by evaluating biological object vision data using Lidar Vision and Open CV-based Object Detection. By combining self-developed biomaterial machine vision technology and robot technology, it intends to expand into a company that delivers core services to diverse industrial sites such as manufacturing, food, andmedical.
Show all investments...

Ulmus Investment
VC Fund · 2 investments in South Korea Life Science startups

Ulmus Investment

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Manufacturing
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United Kingdom

Investor stats

  • Total investments: 19
  • Round size: Series A $3k–$63M; Series B $5M–$26M; Series C $6k–$33M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Dnotitia — Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.
  • Quantum AI — Quantum AI is an AI data company that offers offline and online data collection and analysis services.
  • MakinaRocks — Founded in December 2017, MakinaRocks is a startup specializing in industrial machine intelligence solutions. The company develops industrial AI solutions and a machine learning platform. MakinaRocks’s solutions mitigate the challenges of industries sites—optimizing production quality and process efficiency of the automotive, energy, semiconductor,and battery sectors. Built for ML engineers, MakinaRocks’s end-to-end ML platform covers integral machine learning and model development processes, enhancing while simplifying the transition to AI.
Show all investments...

Aju IB Investment
VC Fund · Yeoksamdong, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Aju IB Investment is a venture capital firm that offers SMEs with investments and consulting services.Aju IB Investment offers consulting services that focus on business management, tax, accounting, legal, mergers and acquisitions, additional funding, marketing, and technology support.Aju IB Investment was founded in September 1974 and is basedin Seoul, South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 106
  • Lead/follow: no public data

Portfolio highlights

  • Gangnam Unni — Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medicalinformation and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries.The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases.As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.
  • Healing Paper — Healing Paper is a mobile healthcare and information technology company.
  • Kovis Technology — Kovis Technology is a manufacturer of measurement and inspection equipment intended for global semiconductor and electronic industries.
Show all investments...

Devsisters Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Venture Capital firm in Korea. We are interested in early-stage investment in gaming, healthcare/biotech, IT services and high technology companies.

Show more...

Investment focus

  • Industry: Software, Gaming, Biotechnology
  • Stage:Series A, Seed
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 107
  • Round size: Seed $1k–$3M; Series A $3k–$7.8M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • StudioBside — StudioBside is a mobile game developer based in Korea.
  • Beyond Honeycomb — Beyond Honeycomb is a food-tech company developing an AI-driven kitchen robot solution. Our AI Chef reproduces the texture and taste of the world-class chef’s dish at the molecular level.
  • AWESOME Entertainment — AWESOME Entertainment is a media and digital content company that provides YouTube content production, influencer and MCN management, advertising and branded content creation, and media commerce services. The comapny supports brands with campaign planning, viral video production, and distribution across multiple social platforms, while alsooffering production outsourcing and partnership services to maximize audience reach and engagement.
Show all investments...

Korea Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Korea Investment Partners (KIP) is a leading venture capital & private equity firm that has over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. Korea Investment Partners invests in leading pioneers like Kakao(KOSDAQ:035720), Naver(KRX:035420), YGEntertainment(KOSDAQ:122870), Bodyfriend, Osstem Implant(KOSDAQ:048260), Doubleu Games(KOSDAQ:192080) and Didi Chuxing. KIP manages over 20 venture and private equity funds with US$1.8 billion in total assets under management. The company operates globally from its Seoul headquarters office with other locations in Shanghai, Beijing, and Sunnyvale.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 434
  • Round size: Seed $973k–$11M; Series A $1.9M–$23M; Series B $2.7M–$50M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $6.7M in 2014

Portfolio highlights

  • 90days — 90days is an electronic bill-based P2B investment brokerage platform.
  • New Id
  • Art Together — Art Together is a crowdfunding platform to buy an artwork.
Show all investments...

SJ Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

SJ Investment Partners is a venture capital firm that invests in the IT and biotechnology industries.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Medical
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Hong Kong

Investor stats

  • Total investments: 75
  • Round size: Seed $547k–$2.3M; Series A $1.5M–$13M; Series B $4M–$28M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Deaver — Deaver is an app for delivery management services.
  • Eleven O'Clock — Eleven O'Clock is a space management platform that offers non-face-to-face cleaning of accommodation facilities. The company's platform Keeper innovates space operation and management as the new standard for space management. The efficiency and quality of space management are improved according to the systematic manual of the Keeperplatform. The platform records and communicates every process as data, from management manuals to space status checks.
  • Real Estate Planet — Real Estate Planet is an AI-based real estate platform that provides transaction prices, investment, and management information.
Show all investments...

UTC Investment Co.
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Since its incorporation in 1988, UTC Investment has been implementing and developing private equity investments with deep roots in buyout area, diversified human resources, and an impressive track record as a leading global investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 120
  • Round size: Series A $2.2M–$13M; Series B $2M–$20M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Beamworks — Beamworks is a research-centered company in medical imaging and conversational AI, that enables expert-level cancer diagnosis anywhere in the world and providing reliable medical consultations at any time. The company's platform utilizes an on-device AI system that processes ultrasound data in real-time without the need for serverconnectivity, achieving detection sensitivity and differential diagnosis performance, enabling healthcare providers to offer precise and timely diagnostics and improve patient outcomes, and reduce unnecessary procedures.
  • CanLab — CanLab is a developer of AI sensors that focuses on creating optical and thermal cameras, as well as real-time image processing platforms for ground, aerial, and marine mobility. Its product offerings include the Vision Camera, Edge AI Platform, Equipment for Thermal Cameras, and Automotive Camera MES.
  • AD System — AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.
Show all investments...

Kakao Ventures
VC Fund · Seongnam, Kyonggi-do, South Korea · 2 investments in South Korea Life Science startups

We are an independent subsidiary of Kakao Corp. & the most active, startup-friendly early stage VC of Korea. (Limited Partnerships, not strategic.).

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, Indonesia

Investor stats

  • Total investments: 319
  • Round size: Seed $297k–$4.2M; Series A $891k–$14M; Series B $3M–$27M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $9.6M in 2012

Portfolio highlights

  • LifeLabs — LifeLabs is a Canadian-owned company that has been serving the healthcare needs of Canadians for more than 50 years. Today, LifeLabs performs more than 100 million laboratory tests every year, helping healthcare providers diagnose, treat, monitor and prevent disease in patients.LifeLabs is strongly committed to continual innovation in testingservices. For our patients and healthcare providers, this means we always strive to provide access to the latest specialized clinical tests—to detect cancer for example, to monitor heart disease, identify neurological disorders and pinpoint allergies.LifeLabs is well-positioned to deliver care at home, in the community and across Ontario and British Columbia. We have over 5,400 professionally trained staff members, over 360 conveniently located patient service centres and an extensive network of couriers and mobile phlebotomists on the job.
  • MakeDashy — Maximize repeat purchases with targeted user segmentation and dynamic product recommendation at Retentics, powered by AI
  • Tect Group — We deliver real beauty based on distinctive brands and innovative marketing solutions, fostering confidence and positivity around the world.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Medytox Venture Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Medytox Venture Investment is a TIPS operator that provides opportunities and supports growth in the healthcare sector.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Medical
  • Stage:Series A, Series B, Series C
  • Geography: South Korea

Investor stats

  • Total investments: 18
  • Round size: Series A $3k–$16M; Series B $4k–$44M; Series C $3.2M–$19M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Nex Eye — Nex Eye is a start-up that develops first-in-class antibodies targeting refractory factors of immuno-oncology drugs.
  • Dime Bio — Dime Bio is a drug development company for novel dementia treatments.
  • Inventera Pharmaceuticals — Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.
Show all investments...

Industrial Bank of Korea
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Industrial Bank of Korea (IBK) is committed to honoring its charter of financing small and medium sized enterprises (SMEs). The Bank has extended the scope of its expertise to provide a comprehensive range of financial services to individual customers in a quest to emerge as a leading financial services group. In pursuit of that goal, IBK is makingevery effort to enhance its competitiveness, achieve balanced growth and strengthen its global presence.The Bank employs around 10,000 staff and operates a distribution network of 612 branches including 12 overseas branches. Providing complementary services, the Bank also operates several subsidiaries: IBK Capital Corporation, IBK-SG Asset Management, IBK System Co., Ltd., and IBK Credit Information Corporation. In 2008, IBK Investment & Securities was launched, focused on meeting the needs of SME customers for services such as IPOs and M&As. Moreover, strategic alliance with Korea Investment Holdings enhances product competitiveness and affiliation with the National Post Office promoting easy customer access to IBK banking services.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 285
  • Round size: Seed $149k–$8.3M; Series A $2M–$17M; Series B $4.8M–$29M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • BIGC — BIGC is a technology company that offers digital marketing, content creation, and advertising services.
  • Gadget Korea — Gadget korea offers data roaming services.
  • Flexell Space — FLEXELL SPACE primarily focuses on the development and manufacturing of space solar cells, aiming to provide differentiated products for our customers in the space industry
Show all investments...

BSK Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

BSK Investment is a private equity investment company that invests in unlisted companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: South Korea

Investor stats

  • Total investments: 46
  • Round size: Series A $2.4M–$57M; Series B $2.8M–$25M; Series C $13M–$24M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • AITRICS — AITRICS is taking on the ultimate role of giving everyone access to the power of data-driven health intelligence by developing advanced clinical solutions that will revolutionize their lives. With a shared vision and a common purpose, passionate and dedicated professionals from diverse backgrounds came together to create the most exceptional team.
  • Sionic AI — We provide cutting-edge Generative AI technology seamlessly to your current service. Prepare future with Sionic AI and make your business great again!
  • BOS Semiconductors — Driving the Future of Automotive, BOS Semiconductors
Show all investments...

Yuhan Corporation
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Yuhan Co, Ltd. is a South Korean pharmaceutical and chemical company.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series C, Corporate Round
  • Geography: South Korea

Investor stats

  • Total investments: 17
  • Round size: Series B $13M–$40B; Series C $7.3M–$32M; Corporate Round $2k–$12M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • J INTS BIO — J INTS BIO is a biotechnology company focused on the research and development of anticancer drugs and orphan medicines. The company develops targeted therapies for conditions such as non-small cell lung cancer and solid tumors.
  • Kim Cell & Gene — Kimcell & Gene is creating antibody treatments that target resistance.
  • Nobo Medicine — Nobo Medicine is a clinical-stage biotech company focused on developing precision therapies for blood cancers and immune-related aging diseases. It uses biomarker-driven drug discovery and translational research to identify targeted treatments, aiming to improve outcomes in oncology and age-associated immune dysfunction through innovative,data-driven biomedical approaches.
Show all investments...

Boditech Med
VC Fund · Chuncheon, Kangwon-do, South Korea · 2 investments in South Korea Life Science startups

Boditech Med provides reliable In-Vitro Diagnostic Solutions for everyone at anywhere, and anytime.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Bioinformatics
  • Stage:Seed, Series A
  • Geography: South Korea

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Leobio — Leobio is a biotechnology company that provides antibiotic alternatives based on bacteriophages.
  • TSD Life Sciences — TSD Life Sciences is a bio company that provides clinical research services to defeat cancer through research and development.
Show all investments...

Coolidge Corner Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Coolidge Corner Investment (CCVC) provides Seed and Seed+ funding to the most innovative tech startup companies in Korea. They proudly provide their portfolio companies a customized support in professional incubating, growth hacking, strategy, network and more.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, Belgium

Investor stats

  • Total investments: 112
  • Round size: Seed $223k–$1.5M; Series A $891k–$5.4M; Series B $4.7M–$11M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Frefins — Frefins is a specialized Rental Transformation (RX) company that generates value by connecting businesses, financial institutions, and consumers.
  • Law&Company — {{ metaDescription }}
  • Partridge Systems — Partridge Systems develops automotive data platform that provides web-based visualization, filtering, and post-processing of vehicle data.
Show all investments...

HG Initiative
VC Fund · Seongdong, Kyonggi-do, South Korea · 2 investments in South Korea Life Science startups

HGI runs an impact-driven business, seeking to address diverse social issues through sustainable innovations.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $360k–$4M; Series A $1M–$8.2M; Series B $3.8M–$13M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Sankun — Sankun offers a digitalized platform that takes a role in establishing the link between buyers and vendors of industrial items.
  • Brewguru — Brewguru is an online beverage store that makes and sells healthy beverages.
  • Dolbom-ui-sin — Caregiver is a specialized platform operator that provides hospitals with advanced nursing solutions, streamlining patient care coordination, enhancing clinical workflows, and supporting specialized nursing practices through intelligent tools and integrated digital systems.
Show all investments...

Quantum Ventures Korea
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Quantum Ventures Korea actively invests in companies within the Technology and Bio/Healthcare industries. The firm manages a portfolio of early to growth-stage companies and continues to look for opportunities across a range of company stages.

Show more...

Investment focus

  • Industry: Software, Medical, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States

Investor stats

  • Total investments: 75
  • Round size: Seed $1M–$7.6M; Series A $1.5M–$16M; Series B $3.7M–$54M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — raised $34M in 2019

Portfolio highlights

  • Qunova Computing, Inc. — Quantum computing based computing innovations for new materials and drug discovery, and advanced technology solution consulting services.
  • Wavelord
  • Plastal — Plastal is a mechanical and chemical engineering company that offers polymer, metal, and mold injection services. The company specializes in using its core technology required for bonding between metal and plastic resin, mold technology, injection conditions, and milling capabilities, enabling manufacturing companies to avail themselves of theproducts they desire.
Show all investments...

Yuanta Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

A star of private equity market grow up your companies and ascend your potential.

Show more...

Investment focus

  • Industry: Financial Services, Information Technology, E-Commerce
  • Stage:Series B, Series C, Series A
  • Geography: South Korea, Taiwan, Vietnam

Investor stats

  • Total investments: 35
  • Lead/follow: no public data

Portfolio highlights

  • MediMabBio — Creating therapeutic opportunities for the most serious diseases.
  • Selta Square — Selta Square is an AI-based drug monitoring company that provides full-cycle drug monitoring solutions using artificial intelligence technology.
  • Pin Therapeutics — Pin Therapeutics is founded in Feb 2017, fast growing stage with member composition of 25% in USA and 75% in Korea. Drug discovery leaderships are from global pharma and biotech companies along with talented scientists both in Korea and USA.* Active Focus - PinE3: E3 ligase screening cascade for identifying novel warheads - PinGLUE: Assaycascade for molecular glue degrader screening* Programs - Selective Molecular Glue Degrader (CK1α) - Molecular Glue Degrader Programs (5-6 Undisclosed) - PROTAC Program (1 Undisclosed)
Show all investments...

Stick Ventures
VC Fund · Seongnam, Kyonggi-do, South Korea · 1 investments in South Korea Life Science startups

Stick Ventures is a venture capital firm based in South Korea that prefers to invest in seed-stage, early-stage, and later-stage companies.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Pharmaceutical
  • Stage:Series B, Series A
  • Geography: South Korea

Investor stats

  • Total investments: 38
  • Lead/follow: no public data

Portfolio highlights

  • Robros — Robros is constantly creating technology to break through the barrier between people and robots in order to build a world in which everyone in the service industry can live a physically and emotionally happy life.
  • Ettifos — Ettifos provides flexible, reliable, and innovative V2X solutions to enable communication between all stakeholders on the road.
  • Imagoworks — Imagoworks Inc. offers a Web-based Dental CAD solution using AI, streamlining the digital workflow for dental professionals. Together with world-class technology, we are setting new standards for digital dentistry in the global market. Our mission is to <Making the future of digital medicine for everyone>.While we have accumulatedtechnological expertise in the medical field for over 10 years, specializing in AI-based automation, 3D geometric modeling and mesh processing, and software as a service (SaaS), we now turn our focus to commercializing our innovative technologies and transforming the field of digital dentistry. By cooperating with and licensing to leading global dental companies, we are seeing great success as we find ourselves in the industry spotlight.Imagoworks currently offers Dentbird Crown which automatically generates optimal crown designs with a single click and without any software installation required. As we continue to expand our services, Imagoworks aims to be recognized as a chairside design solution for dentists worldwide.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Mirae Asset Capital
VC Fund · Mumbai, Maharashtra, India · 1 investments in South Korea Life Science startups

Mirae Asset Capital Market is a leading global investment banking, securities and institutional business firm that provides a wide range of financial services to a substantial and diversified client base.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 133
  • Round size: Series A $6k–$47M; Series B $5.5M–$105M; Series C $14M–$255M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • Asteromorph — We are an AI for Science lab in Seoul. Our mission is to accelerate scientific advancements through the pursuit of superintelligence.
  • Ohouse — No.1 Interior Onestop Platform
Show all investments...

Shinhan Venture Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

Shinhan Venture Investment operates as an investment company. Shinhan Venture Investment focuses on earlier-stage venture capital investments and later-stage control investments opportunities derived from the latest megatrends such as the aging population, disruptive technologies, IT convergence, alternative energy and etc.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Software
  • Stage:Series B, Series A
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 203
  • Round size: Series A $2.2M–$23M; Series B $6.3M–$45M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
  • Return Zero — AI, ASR, Diarization, Speech, ML
  • Subtle Medical — Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow.The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant tofacilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers.Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.
Show all investments...

Clarevoyant Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

At Clairvoyant Ventures, we believe the most transformative innovations emerge from bold, unconventional ideas. As a venture capital firm specializing in Deep Tech, we invest in disruptive technologies that push the boundaries of science and engineering, redefining industries and shaping the future.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: South Korea

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GenKOre — GenKOre operates as a biotech company, specializing in genetic scissors.
  • Dotter — Dotter is a manufacturing company that designs and produces biodegradable optical coherence tomography devices to diagnose and treat cardiovascular diseases. The company also develops next-generation OCT equipment, an optical imaging device that can create a synergy effect when inserting stents.
Show all investments...

Kiwoom Investment
VC Fund · Youidodong, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 16 in the past 12 months

Kiwoom Investment provides financial assistance with funding for small businesses.

Show more...

Investment focus

  • Industry: Information Technology, Software, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 106
  • Round size: Series A $1.2M–$14M; Series B $3.3M–$22M; Series C $11M–$33M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Dnotitia — Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.
  • MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
  • Featuring — Featuring’s goal is to make it easy for anyone to see and utilize the power of influencers. Today, as companies are accelerating their transition to digital business due to COVID-19, the number of companies leveraging influencers is explosively increasing. Feauturing allows brands and marketers to discover product fit influencers and helps matchingbased on their needs. Currently, over 3,600 brands are using Featuring and more than 8,500 influencer campaigns have been done. As a Korea-based startup, Featuring plans on expanding the business to Far East Asia including Japan and China.
Show all investments...

Kingo Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

Kingo Investment Partners is a venture capital firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series C, Series A, Series B
  • Geography: South Korea

Investor stats

  • Total investments: 20
  • Round size: Series A $2k–$9.4M; Series B $11M–$20M; Series C $3.2M–$37M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • IMBiologics — IMBiologics is a biotechnology company that develops immunomodulatory antibody drugs for physiological balance.
  • Colosseum — Colosseum is a logistics company that provides e-commerce logistics services to various locations.
  • PEOPLE & TECHNOLOGY — PEOPLE AND TECHNOLOGY provides DX-based AI solutions on INDOOR GEOLOCATION AND SMART SENSING through its INDOORPLUS+ IoT, Location Based System (LBS) and Real Time Location System (RTLS) platform in the fields of healthcare, manufacturing, defense, smart cities, and the public sector.More than 100 corporate customers in various business sectorssuch as healthcare, banking, manufacturing, retail, energy and public services have already chosen PEOPLE AND TECHNOLOGY to deploy industry grade solutions for employee safety, asset tracking & monitoring, security & access control, flow management and process efficiency. They have gained improvements in productivity and process efficiency while reducing their corporate risks and optimizing their procurement. Since its foundation in 2013, PEOPLE AND TECHNOLOGY has become a leading provider in South Korea and is expanding overseas.
Show all investments...

Neoflux
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

Neoflux is a venture capital firm based in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Software, Apps, Information Technology
  • Stage:Series A, Series B
  • Geography: South Korea, United States

Investor stats

  • Total investments: 7
  • Round size: Series A $1.7M–$7.4M; Series B $3k–$10M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Grip — Grip is a mobile application that offers to sell products, update stories, go online and chat communication to sellers.
  • Thingsflow — Thingsflow is a chatbot that engages in the development and operation of the character chatbot brand Hellobot.
  • Novelty Nobility — Novelty Nobility Inc. is a private biotech company. They are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in ophthalmology and oncology, where angiogenesis plays a key pathogenic role.In ophthalmology, Novelty Nobility first discovered a novel angiogenesis target, Stem Cell Factor(SCF)and c-KIT, which was initially known for its engagement with proliferation and survival of primitive hematopoietic stem cells for a couple of past decades. We believe that anti-SCF/c-KIT could effectively address the unmet medical needs, mostly caused by inherent limitations of anti-VEGFs, in terms of treatment efficacy and long-term safety. Our target discovery is widely and strongly patent-protected in US/KOR and the lead pipeline, NN2101(a full-human monoclonal antibody), is currently under preclinical development.
Show all investments...

Timepolio Asset Management
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 6 in the past 12 months

Timepolio Asset Management is an asset management firm.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 50
  • Round size: Series A $2.4M–$17M; Series B $9k–$19M; Series C $9.1M–$81M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Bone — Bone is a defense tech company. It builds autonomous drones and mission-ready AI systems. It integrates advanced hardware, intelligent software, and end-to-end solutions to support complex operations across commercial, industrial, and defense applications. It develops autonomous robotics systems for national defense and disaster response.
  • Meissa — Meissa is a drone-based construction tech startup that provides real-time 3D mapping and modeling.
  • Next Level Studio — Next Level Studio is a group of creative experts dedicated to generating new value for intellectual property.
Show all investments...

Cytogen
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment systems for cancer diagnosis and treatment in South Korea. It offers Smart Biopsy, an automated CTC enrichment system from blood sample; and cell isolators, IF stainers, cell image analyzers, time laps analyzers, isolation kits, and culture kits. The company was founded in2010 and is headquartered in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Pharmaceutical
  • Stage:Series A
  • Geography: South Korea

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Wellmarker Bio — Their Company has developed a biomarker-based cancer drugs based on accumulated developmental experience and know-how. They have a new drug development institute including synthetic and bio-research and management support center.Utilizing R&D infrastructure from Asan Medical Center in Seoul Republic of Korea they are focusing on developingnew drugs that overcome resistance of existing therapeutic approaches.Additionally they are focusing on developing first-in-class biomarker-based drugs for medical unmet needs in various cancers such as colon cancer, lung cancer and liver cancer.
  • TSD Life Sciences — TSD Life Sciences is a bio company that provides clinical research services to defeat cancer through research and development.
Show all investments...

Widwin Investment
VC Fund · Gangneung, Kangwon-do, South Korea · 1 investments in South Korea Life Science startups

Widwin Investment is an investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series B, Series C, Series A
  • Geography: South Korea, United States

Investor stats

  • Total investments: 12
  • Round size: Series A $6.2M–$7.4M; Series B $497k–$47M; Series C $33M–$45M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Rodwin — Rodwin is a transportation management company specializes in vehicle consignment transportation services.
  • SMALL MACHINES — SMALL MACHINES specializes in the production of AI-driven medical diagnostic analyzers. The company focuses on the development of Cardiac Point Of Care Testing (POCT) devices specifically designed for use in emergency rooms. Additionally, it offers Lab-on-a-Chip OEM/ODM services and is engaged in the creation of digital healthcare platforms.
  • PineTree Therapeutics — PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
Show all investments...

JCurve Investment
VC Fund · Seocho, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

JCurve Investment is a venture capital firm that invests in the veterinary and pharmacy sectors.

Show more...

Investment focus

  • Industry: Medical, Pet, Apps
  • Stage:Series A, Series B, Seed
  • Geography: South Korea

Investor stats

  • Total investments: 6
  • Round size: Series B $4.6M–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Petner — Petner is a startup that connects professionals of pets and guardians of pets.
  • Stockeeper — Stockeeper creates and operates a Korean beef asset platform, Bankau, that connects consumers and producers.
  • INTAKE foods — INTAKE foods (인테이크푸즈) is a company focused on food content development and food branding, specialized in the innovation of leading food brands. It is focused on brand development, content development and publishing, such as food activities, intake of foods, and a food culture of innovation.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ost Investment
VC Fund · 1 investments in South Korea Life Science startups

Ost Investment

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed
  • Geography: South Korea

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pinot Bio — Pinot Bio is a biotechnology company that specializes in developing new generation anticancer treatments.
  • Dr.Kitchen — Kitchen Doctor engages in research and development of diet programs for diabetes. Kitchen Doctor is based in Daejeon, South Korea with an additional office in Seoul, South Korea.
  • Bionetix Therapeutics — Bionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment. The company's drugs include medicines for ophthalmic disease and glaucoma treatment, enabling patients to get early treatment for eye diseases, cancer and other diseases with unmet needs.
Show all investments...

Future Science and Technology Holdings
VC Fund · Daejeon, Taejon-jikhalsi, South Korea · 1 investments in South Korea Life Science startups

Future Science and Technology Holdings is an investment company that specializes in technology-based services.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Food and Beverage
  • Stage:Seed, Series A
  • Geography: South Korea, United States

Investor stats

  • Total investments: 33
  • Round size: Seed $231k–$1.7M; Series A $1.9M–$3.7M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Caretive
  • Protier Biotech — PROTIER Biotech is a company leading the development of therapeutics through innovative biotechnology .
  • Copper Innovation Technology — CIT Co, Ltd utilizes metal single crystals and the ASE method to ensure the accurate, lossless transmission of every signal.
Show all investments...

KB Securities
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 16 in the past 12 months

KB Securities is a Financial Services company.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series B, Series A, Post-IPO Equity
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 152
  • Round size: Series A $2.5M–$12M; Series B $4.1M–$22M; Post-IPO Equity $82–$202k
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Korean Air — Korean Air provides passenger air transportation, air cargo logistics, and related travel services through scheduled and charter flight operations. The company transports passengers between international and domestic destinations and manages ticketing, reservations, and in-flight services through its digital platforms and airport operations. Itscargo division handles freight transportation, including general cargo, special shipments, and charter logistics, and supports shipment tracking and electronic air waybill processing. The company also operates integrated logistics services such as trucking connections that link air routes with ground transport networks for cargo delivery. In addition, Korean Air runs programs that allow cargo customers to measure and reduce transportation-related carbon emissions through the use of sustainable aviation fuel initiatives.
  • Upstage — Upstage AI is an artificial intelligence (AI) startup that helps companies focus on their core businesses.
  • Seeann Solution — integrated PSI manufacturer Seeann Solution
Show all investments...

Time Folio Asset Management
VC Fund · 1 investments in South Korea Life Science startups

Time Folio Asset Management

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series B, Series C, Series A
  • Geography: South Korea, United States

Investor stats

  • Total investments: 16
  • Round size: Series A $4.8M–$26M; Series B $11M–$27M; Series C $11M–$33M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Monday OFF — MondayOFF is a mobile games developer and publisher specialized in Hypercasual games. With creativity and constantly evolving methods, we aim to launch your game to the top of the charts and build a worldwide audience to enjoy your games.
  • IVIM Technology — Global No.1 solution provider of IntraVital Microscopy
  • Point2 Technology — We Develop Innovative, Ultra-Low Power Connectivity SoCs Point2 Technology cloud-optimized range of high-speed SoCs and reference design platforms accelerate deployment of next generation data centers and 5G infrastructure.
Show all investments...

JX Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

JX Partners is a venture capital firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Biopharma
  • Stage:Series A, Series C, Series B
  • Geography: South Korea

Investor stats

  • Total investments: 9
  • Round size: Series A $5.9M–$7.4M; Series B $8.9M–$11M; Series C $19M–$33M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Curocell — Curocell’s OVIS™ technology enhances immune cells to overcome immune suppression in tumor microenvironments.
  • BeyondBio — BeyondBio is a biotechnology firm that specializes in the research and development of synthetic pharmaceutical drugs.
  • Polaris3D — Polaris3d offers indoor autonomous navigating solution.
Show all investments...

Meritz Securities
VC Fund · 1 investments in South Korea Life Science startups

Securities, Investment, Finance, Trading company

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Pharmaceutical
  • Stage:Series C, Series A, Series B
  • Geography: South Korea, China

Investor stats

  • Total investments: 12
  • Round size: Series A $4.7M–$8.2M; Series B $15M–$21M; Series C $15M–$37M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Dime Bio — Dime Bio is a drug development company for novel dementia treatments.
  • LDCarbon Co. — LDCarbon Co. is a manufacture of green carbon black, pyrolysis oil, and waste tire powder.
  • Lanvin Group — Lanvin group is a fashion industry that oversees the labels lanvin, caruso, wolford, sergio rossi, and st. John knits. It is offering this assistance along with in-depth information about and connection to the fashion markets.
Show all investments...

Nice Investment Partners
VC Fund · Yongdungpo, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 7 in the past 12 months

NICE Investment Partners is a new technology finance company whose main job is to increase corporate value by discovering and investing in new technology businesses with promising growth, providing various management support, business alliances, and strategic consulting to the invested companies.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, Japan

Investor stats

  • Total investments: 57
  • Round size: Seed $1k–$1.7M; Series A $2.1M–$22M; Series B $5k–$16M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Pensées — Pensées is a 3D bio-printer company that develops cultured meat through 3D bioprinting technology.
  • Biocom — Biocom is a green bio management company.
  • Motif Technologies — Motif Technologies is an AI deep tech company that develops proprietary AI models and provides optimized cloud infrastructure for AI deployment, from everyday personal use to enterprise-scale applications.
Show all investments...

Quad Asset Management
VC Fund · 1 investments in South Korea Life Science startups

Quad Asset Management is an Investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Medical
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States

Investor stats

  • Total investments: 39
  • Round size: Series A $1.5M–$19M; Series B $4.5M–$42M; Series C $9.2M–$33M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
  • Mediwhale — Mediwhale develops AI medical devices that analyze retinal images to predict cardiovascular, kidney, and eye disease risks early.
Show all investments...

IBK Capital
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 12 in the past 12 months

IBK Capital is the venture capital arm of the Industrial Bank of Korea (IBK).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 111
  • Round size: Seed $2k–$7.6M; Series A $720k–$8.2M; Series B $7k–$21M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Willog — As a fast-growing startup, Willog provides a “item-level condition monitoring” that innovates the supply chain of sensitive, perishable or valuable goods where condition monitoring is required, and its efforts are to create a transparent and connected logistics flow. Based on its patented sensor technology and its cloud-based software, Willog helpscompanies gain seamless visibility down to the item-level and control over their shipments across their supply chain so they can have condition foresights and insights to improve their bottom line.Willog acquired 25 enterprise customers including MNCs like Hyundai Motor Group and DHL Express since its establishment. Willog is rapidly expanding its presence in various industries including bio-pharmaceutical, fresh food, and special logistics, where condition monitoring is key to business continuity. Going forward, while strengthening its leadership position in Korea, Willog will accelerate global expansion with partnerships in America, Kazakhstan, and Malaysia.
  • Automata — Automata creates AI-powered tools like AI agents and smart integrations that simplify how teams plan, communicate, and work. The company solves business problems by enabling AI to build, manage, and evolve software workflows while humans guide the AI to deliver real value.Automata provides industry-tailored AI solutions
  • PEOPLE & TECHNOLOGY — PEOPLE AND TECHNOLOGY provides DX-based AI solutions on INDOOR GEOLOCATION AND SMART SENSING through its INDOORPLUS+ IoT, Location Based System (LBS) and Real Time Location System (RTLS) platform in the fields of healthcare, manufacturing, defense, smart cities, and the public sector.More than 100 corporate customers in various business sectorssuch as healthcare, banking, manufacturing, retail, energy and public services have already chosen PEOPLE AND TECHNOLOGY to deploy industry grade solutions for employee safety, asset tracking & monitoring, security & access control, flow management and process efficiency. They have gained improvements in productivity and process efficiency while reducing their corporate risks and optimizing their procurement. Since its foundation in 2013, PEOPLE AND TECHNOLOGY has become a leading provider in South Korea and is expanding overseas.
Show all investments...

The Wells Investment
VC Fund · 1 investments in South Korea Life Science startups

The Wells Investment

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: South Korea

Investor stats

  • Total investments: 10
  • Round size: Series A $2.2M–$13M; Series B $10M–$15M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • ADDD — Dalgo is a peer-to-peer advertising platform.
  • GenKOre — GenKOre operates as a biotech company, specializing in genetic scissors.
  • Oasis Business — Oasis Business is an information services company that provides AI solutions to the finance, construction, and distribution industries.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Premier Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 13 in the past 12 months

Premier Partners (프리미어 파트너스) is a Korean domestic funds management company. It provides investment services for individuals and businesses. Premier Partners was established in September 2005 in Seoul, Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Series B, Series A
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 155
  • Round size: Series A $2.2M–$22M; Series B $5.3M–$45M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $82M in 2023

Portfolio highlights

  • XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
  • Asteromorph — We are an AI for Science lab in Seoul. Our mission is to accelerate scientific advancements through the pursuit of superintelligence.
  • Akisostem BioStrategies — Archisostem BioStrategies is a research and development company.
Show all investments...

HB Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 12 in the past 12 months

HB Investment Inc. was founded on November 11, 1999 starting with paid-in Capital of KRW 10 billion.Since its foundation, HB Investment Inc. has been investing small and medium businesses that have the potential for steady growth and profitability and helping the invested companies to grow well by giving various consulting services. As a result,HB Investment Inc.constructed comprehensive portfolio out of various industrial areas, such as game, entertainment, as well as representative high-tech industries related to semiconductor, Internet, LCD, and a smart phone, bio, health care. In addition, HB Investment Inc. has experiences in implementing business Success-fully by organizing several partnership funds for recent years.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Series B, Series A
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 144
  • Round size: Series A $1.1M–$15M; Series B $3.7M–$23M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Robros — Robros is constantly creating technology to break through the barrier between people and robots in order to build a world in which everyone in the service industry can live a physically and emotionally happy life.
  • Dnotitia — Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.
  • Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
Show all investments...

Stonebridge Ventures
VC Fund · Thika, Central, Kenya · 1 investments in South Korea Life Science startups

Stonebridge Ventures was founded in 2008

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Software
  • Stage:Series B, Series A, Seed
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 33
  • Round size: Seed $1M–$2.2M; Series A $736k–$17M; Series B $3M–$14M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Portal 301 — PORTAL301 is a tech startup focused on transforming the UI/UX in the robotics industry. It focus is on the nuclear power plant decommissioning and powder coating sectors.
  • Narnia Labs — Narnia Labs is the developer of artificial intelligence-based design software designed to provide domain-based three-dimensional synthetic data. The company's software provides design creation, evaluation, optimization, and recommendation services, enabling clients from engineering and industrial design fields to develop performance bycollaborating with AI, from manufacturing to architecture, medicine, and the metaverse.
  • Labrador Labs
Show all investments...

SV Investment Corp
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

SV Investment Corp is a venture capital firm that provides companies with finance, strategic advice and information at critical stages of their development.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 105
  • Round size: Seed $1.2M–$31M; Series A $1.6M–$24M; Series B $7.1M–$60M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
  • Asteromorph — We are an AI for Science lab in Seoul. Our mission is to accelerate scientific advancements through the pursuit of superintelligence.
  • Contents Technologies — Content Technologies is a content IP-based company builder.
Show all investments...

P&I Investment
VC Fund · Seongnam, Kyonggi-do, South Korea · 1 investments in South Korea Life Science startups

P&I Investment is a venture capital firm based in South Korea.

Show more...

Investment focus

  • Industry: Music, Content, Software
  • Stage:Series A, Seed
  • Geography: South Korea

Investor stats

  • Total investments: 4
  • Round size: Series A $7.4M–$36M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • CLUSH — Clush is an AI and cloud infrastructure company that builds enterprise software to help organizations develop, deploy, and manage AI systems. The company offers cloud-native services and products, enabling customers to build, manage, and collaborate on cloud-based applications and data. Clush provides products such as Clush Kube MLOps, AIgovernance platforms, AI agents, hybrid cloud infrastructure, and enterprise collaboration tools for industries including finance, manufacturing, and public sector organizations
  • OASYS STUDIO — ​OASYS STUDIO is a cloud-native visual effects company that integrates VFX pipeline services and production within a cloud environment. They offer scalable and efficient production solutions, fostering stable collaboration structures for clients.
  • Contents Technologies — Content Technologies is a content IP-based company builder.
Show all investments...

Partners Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 9 in the past 12 months

As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 126
  • Round size: Series A $2.1M–$26M; Series B $5.2M–$117M; Series C $7.4M–$87M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
  • Solivis — Solivis is a solid electrolyte company that develops secondary batteries for next-generation electric vehicles.
  • Cenyx Biotech — Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.
Show all investments...

BNH Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 7 in the past 12 months

BNH Investment is an investment company for bio and healthcare sectors.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Medical
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States

Investor stats

  • Total investments: 34
  • Round size: Series A $7k–$13M; Series B $6.1M–$20M; Series C $8.2M–$23M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • ENCell — ENCell is a biotech company that develops and manufactures biopharmaceuticals.
  • Mustbio — MustBio is a biotechnology company that leverages multi-antibody technology to develop therapeutics primarily in the field of immuno-oncology. The company was founded in 2021 and is based in Seoul, South Korea.
  • LabInCube — LabInCube develops inCube materials capable of selective drug release, sustained release, and supporting complex raw materials.
Show all investments...

STIC Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

STIC Ventures invests in small and mid-sized venture companies with core technologies and new business models.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Information Technology
  • Stage:Series A, Series B
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 127
  • Round size: Series A $2M–$44M; Series B $5.2M–$46M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
  • Asteromorph — We are an AI for Science lab in Seoul. Our mission is to accelerate scientific advancements through the pursuit of superintelligence.
  • Pebble Square — Pebble Square's new Processing-In-Memory (PIM) architecture is a significant advancement for AI performance and power efficiency.
Show all investments...

Korea Omega Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

Korea Omega Investment Finance is a private equity and venture capital firm

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, Vietnam, United States

Investor stats

  • Total investments: 28
  • Round size: Seed $743k–$1.5M; Series A $3.3M–$22M; Series B $5k–$59M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • ActionFit — ActionFit is a video game company with expertise in developing and publishing video games for the mobile platform.
  • Esol — Esol operates a semiconductor equipment business focused on extreme ultraviolet (EUV) technology. It provides EUV pellicle transmittance and mask phase measurement systems, as well as interference patterning equipment, enabling higher-resolution, denser, and more advanced semiconductor chips.
  • MilieMoon — Demi-fine Jewelry for Finer Taste.
Show all investments...

ActnerLab
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

ActnerLab is a venture capital and accelerator that helps hardware, IoT and biotech startups establish their initial foothold and beyond.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Angel
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 103
  • Round size: Seed $37k–$74k; Angel $74k–$111k
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • AltMedical — AltMedical is a research institute jointly established with Dong-A University and aims to develop a treatment for Alzheimer's disease.
  • Chain Lightning — Chain Lightning is an electric vehicle charging station that provides electric vehicle care payment and charge management services.
  • NAiEEL Technology — NAiEEL Technology offers energy and environmental technology solutions.
Show all investments...

Life Science VC funding in South Korea at a glance

Stats across 91 deals from 141 investors.

141
investors
in South Korea Life Science startups
91
deals
in South Korea Life Science startups
$6.6M
median round
in South Korea Life Science startups
18%
lead investors
lead at least one round
24%
Seed
most common funding stage

Access all 141 VC funds in South Korea Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in South Korea investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 141 VC funds investing in South Korea Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists